Pamplona Capital Management Nears Deal to Buy Parexel

Private-equity firm Pamplona is nearing a deal to buy Parexel for $4.6 billion, the latest in a series of mergers among drug-research firms.

from WSJ.com: US Business http://ift.tt/2svYcm9
via IFTTT